Couple-Coordinated Lifestyle Intervention for Women With a History of Gestational Diabetes Mellitus
Effectiveness of a Couple-Coordinated Lifestyle Intervention Among Women With a History of Gestational Diabetes Mellitus
1 other identifier
interventional
362
1 country
3
Brief Summary
The goal of this clinical trial is to evaluate the effects of a couple-based collaborative lifestyle intervention among women with a history of gestational diabetes. The main questions it aims to answer are: Does the intervention improve body mass index and 2-hour plasma glucose after an oral glucose tolerance test? Does the intervention improve health behaviors, psychological well-being, self-efficacy, couple functioning, and life satisfaction? Researchers will compare a couple-based collaborative lifestyle intervention with a woman-only lifestyle intervention to determine whether adding spousal collaboration and support leads to greater improvements. Participants will: Receive healthy lifestyle education posts for 3 months. In the couple-based group, also receive instant messages on behavioral promotion and couple collaboration and support videos.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2026
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2026
CompletedFirst Posted
Study publicly available on registry
August 13, 2026
CompletedStudy Start
First participant enrolled
August 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2028
Study Completion
Last participant's last visit for all outcomes
August 30, 2028
August 13, 2026
August 1, 2026
2 years
August 8, 2026
August 8, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
2 h Oral Glucose Tolerance Test
Two-hour plasma glucose will be measured 2 hours after a 75-g oral glucose load during an oral glucose tolerance test and reported in mmol/L.
Baseline and 6 months
Body Mass Index
Body mass index will be calculated as weight in kilograms divided by height in meters squared (kg/m²).
Baseline, 3 months, and 6 months
Secondary Outcomes (16)
Fasting Blood Glucose
Baseline and 6 months
Total Cholesterol
Baseline and 6 months
Triglycerides
Baseline and 6 months
High-Density Lipoprotein Cholesterol
Baseline and 6 months
Low-Density Lipoprotein Cholesterol
Baseline and 6 months
- +11 more secondary outcomes
Study Arms (2)
Couple-based Collaborative Lifestyle Intervention arm
EXPERIMENTALWomen with a history of gestational diabetes and their spouses will receive a 3-month couple-based lifestyle intervention consisting of health modules delivered through health education posts, instant messages, and short videos.
Woman-only Lifestyle Intervention arm
ACTIVE COMPARATORWomen with a history of gestational diabetes will receive a 3-month lifestyle intervention delivered through health education posts, without the couple collaboration and support components (instant messages, and short videos).
Interventions
Couples will receive a 3-month lifestyle intervention delivered through health education posts, short videos, and instant messages. The intervention addresses healthy diet, physical activity, and stress management, with smoking cessation and alcohol reduction provided when applicable. Couple-specific components focus on role allocation, couple communication, and time management.
Women will receive a 3-month lifestyle intervention delivered through health education posts focusing on healthy diet, physical activity, and stress management, with smoking cessation and alcohol reduction provided when applicable. The intervention does not include the couple collaboration and support components provided in the experimental group.
Eligibility Criteria
You may qualify if:
- For women:
- to 40 years of age.
- Diagnosed with gestational diabetes mellitus during the most recent pregnancy.
- Have basic literacy and sufficient cognitive and physical ability to participate in the study.
- Living with their spouse.
- Able to use a smartphone.
- Willing to participate in the study.
- For spouses:
- Living with an eligible woman with a history of gestational diabetes mellitus.
- Have basic literacy and sufficient cognitive and physical ability to participate in the study.
- Able to use a smartphone.
- Willing to participate in the study.
You may not qualify if:
- For women:
- Diabetes diagnosed before pregnancy or after delivery.
- Pregnant at the time of screening.
- Currently using medications that affect glucose metabolism or medications for weight loss.
- Cognitive impairment or a serious psychiatric disorder.
- A contraindication to postpartum exercise.
- Current participation in another lifestyle intervention program.
- For spouses:
- A diagnosed major chronic disease, such as coronary heart disease or diabetes, or another serious physical illness.
- Cognitive impairment or a serious psychiatric disorder.
- Current participation in another lifestyle intervention program.
- Women with a history of gestational diabetes mellitus and their spouses will be recruited during postpartum follow-up visits at the participating hospitals. Both members of the couple must meet their respective eligibility criteria.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Changde First People's Hospital
Changde, Hunan, 415003, China
Changsha Central Hospital
Changsha, Hunan, 410004, China
General Hospital of Hunan University of Medicine
Huaihua, Hunan, 418000, China
Study Officials
- PRINCIPAL INVESTIGATOR
Chunxia Cheng
The Third Xiangya Hospital of Central South University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Physician
Study Record Dates
First Submitted
August 8, 2026
First Posted
August 13, 2026
Study Start (Estimated)
August 15, 2026
Primary Completion (Estimated)
August 30, 2028
Study Completion (Estimated)
August 30, 2028
Last Updated
August 13, 2026
Record last verified: 2026-08